-
Je něco špatně v tomto záznamu ?
Positive Modulators of the N-Methyl-d-aspartate Receptor: Structure-Activity Relationship Study of Steroidal 3-Hemiesters
B. Krausova, B. Slavikova, M. Nekardova, P. Hubalkova, V. Vyklicky, H. Chodounska, L. Vyklicky, E. Kudova,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NV15-29370A
MZ0
CEP - Centrální evidence projektů
- MeSH
- alosterická regulace MeSH
- HEK293 buňky MeSH
- konformace proteinů MeSH
- lidé MeSH
- modulátory membránového transportu chemie farmakologie MeSH
- molekulární modely MeSH
- molekulární struktura MeSH
- pregnenolon farmakologie MeSH
- receptory N-methyl-D-aspartátu antagonisté a inhibitory metabolismus MeSH
- steroidy chemie farmakologie MeSH
- vztahy mezi strukturou a aktivitou MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Here, we report the synthesis of pregn-5-ene and androst-5-ene dicarboxylic acid esters and explore the structure-activity relationship (SAR) for their modulation of N-methyl-d-aspartate receptors (NMDARs). All compounds were positive modulators of recombinant GluN1/GluN2B receptors (EC50 varying from 1.8 to 151.4 μM and Emax varying from 48% to 452%). Moreover, 10 compounds were found to be more potent GluN1/GluN2B receptor modulators than endogenous pregnenolone sulfate (EC50 = 21.7 μM). The SAR study revealed a relationship between the length of the residues at carbon C-3 of the steroid molecule and the positive modulatory effect at GluN1/GluN2B receptors for various D-ring modifications. A selected compound, 20-oxo-pregnenolone hemiadipate, potentiated native NMDARs to a similar extent as GluN1/GluN2A-D receptors and inhibited AMPARs and GABAAR responses. These results provide a unique opportunity for the development of new steroid based drugs with potential use in the treatment of neuropsychiatric disorders involving hypofunction of NMDARs.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19028457
- 003
- CZ-PrNML
- 005
- 20201031115452.0
- 007
- ta
- 008
- 190813s2018 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1021/acs.jmedchem.8b00255 $2 doi
- 035 __
- $a (PubMed)29708744
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Krausova, Barbora $u Institute of Physiology of the Czech Academy of Sciences , Videnska 1083 , Prague 4, 142 20 , Czech Republic.
- 245 10
- $a Positive Modulators of the N-Methyl-d-aspartate Receptor: Structure-Activity Relationship Study of Steroidal 3-Hemiesters / $c B. Krausova, B. Slavikova, M. Nekardova, P. Hubalkova, V. Vyklicky, H. Chodounska, L. Vyklicky, E. Kudova,
- 520 9_
- $a Here, we report the synthesis of pregn-5-ene and androst-5-ene dicarboxylic acid esters and explore the structure-activity relationship (SAR) for their modulation of N-methyl-d-aspartate receptors (NMDARs). All compounds were positive modulators of recombinant GluN1/GluN2B receptors (EC50 varying from 1.8 to 151.4 μM and Emax varying from 48% to 452%). Moreover, 10 compounds were found to be more potent GluN1/GluN2B receptor modulators than endogenous pregnenolone sulfate (EC50 = 21.7 μM). The SAR study revealed a relationship between the length of the residues at carbon C-3 of the steroid molecule and the positive modulatory effect at GluN1/GluN2B receptors for various D-ring modifications. A selected compound, 20-oxo-pregnenolone hemiadipate, potentiated native NMDARs to a similar extent as GluN1/GluN2A-D receptors and inhibited AMPARs and GABAAR responses. These results provide a unique opportunity for the development of new steroid based drugs with potential use in the treatment of neuropsychiatric disorders involving hypofunction of NMDARs.
- 650 _2
- $a alosterická regulace $7 D000494
- 650 _2
- $a HEK293 buňky $7 D057809
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a modulátory membránového transportu $x chemie $x farmakologie $7 D049990
- 650 _2
- $a molekulární modely $7 D008958
- 650 _2
- $a molekulární struktura $7 D015394
- 650 _2
- $a pregnenolon $x farmakologie $7 D011284
- 650 _2
- $a konformace proteinů $7 D011487
- 650 _2
- $a receptory N-methyl-D-aspartátu $x antagonisté a inhibitory $x metabolismus $7 D016194
- 650 _2
- $a steroidy $x chemie $x farmakologie $7 D013256
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Slavikova, Barbora $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences , Flemingovo nam. 2 , Prague 6, 166 10 , Czech Republic.
- 700 1_
- $a Nekardova, Michaela $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences , Flemingovo nam. 2 , Prague 6, 166 10 , Czech Republic. Faculty of Mathematics and Physics , Charles University in Prague , Ke Karlovu 3 , Prague 2, 121 16 , Czech Republic.
- 700 1_
- $a Hubalkova, Pavla $u Institute of Physiology of the Czech Academy of Sciences , Videnska 1083 , Prague 4, 142 20 , Czech Republic. Third Faculty of Medicine , Charles University in Prague , Ruska 87 , Prague 10, 100 00 , Czech Republic.
- 700 1_
- $a Vyklicky, Vojtech $u Institute of Physiology of the Czech Academy of Sciences , Videnska 1083 , Prague 4, 142 20 , Czech Republic.
- 700 1_
- $a Chodounska, Hana $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences , Flemingovo nam. 2 , Prague 6, 166 10 , Czech Republic.
- 700 1_
- $a Vyklicky, Ladislav $u Institute of Physiology of the Czech Academy of Sciences , Videnska 1083 , Prague 4, 142 20 , Czech Republic.
- 700 1_
- $a Kudova, Eva $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences , Flemingovo nam. 2 , Prague 6, 166 10 , Czech Republic.
- 773 0_
- $w MED00010049 $t Journal of medicinal chemistry $x 1520-4804 $g Roč. 61, č. 10 (2018), s. 4505-4516
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29708744 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190813 $b ABA008
- 991 __
- $a 20201031115450 $b ABA008
- 999 __
- $a ok $b bmc $g 1433606 $s 1066917
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 61 $c 10 $d 4505-4516 $e 20180504 $i 1520-4804 $m Journal of medicinal chemistry $n J Med Chem $x MED00010049
- GRA __
- $a NV15-29370A $p MZ0
- LZP __
- $a Pubmed-20190813